Lupin Limited
HDFC Life Insurance has slipped off the major shareholder list of Lupin Limited after previously holding a 1.1 percent stake. The insurance company has either exited its position entirely or trimmed the holding below the 1 percent reporting threshold.
An innovation-led pharmaceutical company headquartered in Mumbai, Lupin develops and commercializes a broad range of branded and generic formulations, biotechnology products, and active pharmaceutical ingredients. The company operates as a transnational enterprise, serving customers across more than 100 markets including the United States, India, South Africa, Asia Pacific, Latin America, Europe, and the Middle East regions.
HDFC Life Insurance Company Limited, institutional investor in Indian equities